ANBT
CELG

American National Bank & Trust’s Celgene Corp CELG Stock Holding History

American National Bank & Trust’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-224
Closed -$29K – 273
2017
Q2 		$29K Hold
224
– – 0.01% 173
2017
Q1 		$28K Sell
224
-3
-1% -$359 0.01% 176
2016
Q4 		$26K Buy
227
+3
+1% +$334 0.01% 182
2016
Q3 		$23K Hold
224
– – 0.01% 169
2016
Q2 		$22K Buy
+224
New +$23.2K 0.01% 173

Other funds holding CELG

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

American National Bank & Trust's CELG Position: Q3 2017 in Review

American National Bank & Trust sold out of Celgene Corp (CELG) in Q3 2017, closing a stake of 224 shares — an estimated $29K sold.

American National Bank & Trust first reported a position in CELG in Q2 2016 and held it in 5 quarters. The position peaked at $29K in Q2 2017. 1,484 funds tracked by Wall St. Rank hold CELG as of Q3 2017.

  • American National Bank & Trust reported no remaining Celgene Corp position as of Q3 2017 after selling out during the quarter.
  • American National Bank & Trust sold 224 Celgene Corp shares in Q3 2017, an estimated $29K.
  • American National Bank & Trust first reported a position in Celgene Corp in Q2 2016 and held it in 5 quarters.
  • American National Bank & Trust's Celgene Corp position peaked at $29K in Q2 2017.
  • 1,484 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2017.

Based on American National Bank & Trust's 13F filing for Q3 2017, filed 10 Oct 2017.